Topic Highlight
Copyright ©2011 Baishideng Publishing Group Co.
World J Clin Oncol. May 10, 2011; 2(5): 203-216
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.203
Table 1 Sensitivity rates for detection of malignancy by endoscopic brush cytology of a biliary stricture
Authors and yearCountryPanc cancerBile duct cancerSpecificity
Venu et al[21], 1990USA60% (3/5)80% (20/25)100% (88/88)
Rupp et al[22], 1990USA91% (21/23)100% (6/6)88% (7/8)
Foutch et al[23], 1991USA0% (0/6)100% (5/5)100% (3/3)
Ryan et al[24], 1991USA30% (6/20)44% (4/9)100% (17/17)
Howell et al[25], 1992USA0% (0/18)50% (2/4)100% (5/5)
Kurzawinski et al[26], 1993Great Britain65% (15/23)60% (6/10)100% (7/7)
Ferrari Júnior et al[27], 1994USA66% (16/29)20% (2/10)100% (22/22)
Ponchon et al[28], 1995France15% (3/20)44% (12/25)97% (64/66)
Sugiyama et al[29], 1996Japan36% (5/14)59% (10/17)100% (12/12)
Mansfield et al[30], 1997Great Britain38% (10/28)63% (10/16)100% (2/2)
Vandervoort et al[31], 1999USA11% (5/46)30% (3/10)100% (37/37)
Glasbrenner et al[32], 1999Germany35% (11/31)80% (16/20)90% (19/21)
Jailwala et al[33], 2000USA24% (11/46)23% (7/30)100% (29/29)
Farrell et al[34], 2001USA78% (14/18)60% (6/10)83% (10/12)
Fogel et al[35], 2006USA36% (32/88)26% (10/38)100% (8/8)
Kitajima et al[36], 2007Japan60% (9/15)71% (15/21)100% (7/7)
Table 2 Sensitivity rates for detection of malignancy by endoscopic forceps biopsy of a biliary stricture
Authors and yearCountryPanc cancerBile duct cancerSpecificity
Kubota et al[54], 1993Japan50% (2/4)89% (16/18)100% (5/5)
Ponchon et al[28], 1995France46% (6/13)44% (7/16)97% (35/36)
Sugiyama et al[29], 1996Japan71% (10/14)88% (15/17)100% (12/12)
Jailwala et al[33], 2000USA33% (15/46)30% (9/30)100% (10/10)
Tamada et al[59], 2002Japan50% (6/12)84% (21/25)100% (18/18)
Kitajima et al[36], 2007Japan60% (9/15)57% (12/21)100% (7/7)
Table 3 Intraductal ulytrasonography for the evaluation of longitudinal cancer extension of extrahepatic bile duct carcinoma
Authors and yearCountryRouteAccuracy of IDUS
Tamada et al[110], 1995JapanPTBD/ERCP68% (13/19)
Inui et al[115], 1998JapanPTBD/ERCP85% (11/13)
Fujita et al[116], 1998JapanERCP80% (12/15)
Menzel et al[118], 2000GermanyERCP80% (24/30)
Tamada et al[143], 2001JapanPTBD/ERCP71% (25/35)
Tamada et al[145], 2001JapanERCP84% (16/19)
Kim et al[138], 2010KoreaPTBD92% (18/19)
Table 4 Cholangioscopy for the evaluation of longitudinal cancer extension of extrahepatic bile duct carcinoma
Authors and yearCountryModalityAccuracy
Tamada et al[110], 1995JapanPTCS + mapping biopsy; PTCS + mapping biopsy + IDUS80% (12/15); 93% (14/15)
Sato et al[42], 1998JapanPTCS81% (13/16)
Kawakami et al[72], 2009JapanPOCS; POCS + mapping biopsy77% (10/13); 100% (13/13)
Kim et al[138], 2010KoreaPTCS + mapping biopy; PTCS + mapping biopy + IDUS90% (18/20); 95% (18/19)